Comparison

NAE-IN-M22

Manufacturer ChemScene
Category
Type Molecules
Specific against other
Amount 50mg
Item no. CS-0087489-50mg
eClass 6.1 32169090
eClass 9.0 32169090
Available
CAS
864420-54-2
Purity
>98%
MWt
363.32
Formula
C20H24Cl2N2
Solubility
10 mM in DMSO
Clinical Information
No Development Reported
Pathway
Apoptosis
Target
Apoptosis
Biological Activity
NAE-IN-M22 is a potent, selective and reversible inhibitor of NEDD8 activating enzyme (NAE), with potency in micromolar range. NAE-IN-M22 inhibits multiple cancer cell lines and induces apoptosis in A549 cells. NAE-IN-M22 also can inhibit tumor growth in vivo[1]. IC50 & Target: NEDD8 activating enzyme (NAE)[1] In Vitro: M22 (0.37-90 uM; 24 h) blocks neddylation pathway selectively and suppresses degradation of CRL substrates in A549 cells[1].
M22 (0.1-100 uM; 48 h) inhibits A549 cell proliferation completely at 30 uM (GI50=5.5 uM, GI90=19.3 uM)[1].
M22 (15-30 uM; 36 h) promotes apoptosis in A549 cell line[1]. In Vivo: M22 (60 mg/kg; i.p. once daily for 14 d) inhibits tumor growth in nude mice bearing AGS xenografts[1].
M22 (0.36-90 uM) has low acute toxicity in zebrafish model[1].
Research Area
Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Delivery expected until 7/4/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close